Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer

Clinical trial NCT00900614 · COMPLETED

Trial details

NCT number: NCT00900614
Sponsor: Aprea Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Neoplasms Prostatic Neoplasms

Start date: 2009-05-01
Primary completion: 2010-10-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.